Integrity Health Services

integrityhealth.org

Integrity Health Services is a Florida based medical staffing and pediatric home health company in business since 2004. With offices in Miami, Fort Lauderdale, Jacksonville, Orlando, and Tampa, Integrity has been providing services to pediatric and adult patients throughout Florida for over 10 years. Integrity employs Registered Nurses, Licensed Practical Nurses, Physical Therapists, Occupational Therapists, Speech Therapists, and Certified Nursing Assistants. In doing so Integrity has been providing facility staffing to schools, prisons, nursing homes, hospital systems, and any medically related facilities throughout Florida. Integrity is fully credentialed and accredited by the Accreditation Commission for Health Care (ACHC) and Licensed through the Agency for Health Care Administration (AHCA).

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

AI, Industrial Impact

CIMEIO THERAPEUTICS PRESENTS SCIP PLATFORM PROOF-OF-CONCEPT DATA AT ASH

Cimeio | December 12, 2022

news image

The two studies demonstrate proof-of-concept that genetically engineered variants of cell surface receptors harboring single amino acid substitutions are fully functional but evade a paired immunotherapy directed against the wild-type molecule. This technology will enable the development of more efficient and safer targeted conditioning regimens for hematopoietic stem cell transplantation, gene therapies, and opens the path to more efficient cell and immunotherapy-based treatment approaches for ...

Read More

Industrial Impact, Medical

ASAHI KASEI BIOPROCESS AMERICA AND GEMINIBIO ENTER STRATEGIC PARTNERSHIP TO ADVANCE APPLICATION OF INLINE BUFFER FORMULATION

businesswire | April 20, 2023

news image

Asahi Kasei Bioprocess America, a subsidiary of diversified Japanese multinational company Asahi Kasei, and GeminiBio have entered into a strategic partnership to advance the application of inline buffer formulation (IBF) in the biopharmaceutical industry. Asahi Kasei Bioprocess, with decades of expertise in IBF and the developers of the award-winning MOTIV™ system, and GeminiBio, with industry leading bioprocess liquid manufacturing capabilities, are combining two high-efficiency so...

Read More

MedTech, Industrial Impact

PUMA BIOTECHNOLOGY PRESENTS UPDATED FINDINGS FROM THE TBCRC-022 TRIAL AT THE 2022 SAN ANTONIO BREAST CANCER SYMPOSIUM

Puma Biotechnology | December 08, 2022

news image

Puma Biotechnology, Inc. a biopharmaceutical company, presented updated findings from the Translational Breast Cancer Research Consortium Trial 022 at the ongoing 2022 San Antonio Breast Cancer Symposium in San Antonio, Texas. The poster entitled “Neratinib and ado-Trastuzumab-Emtansine for HER2+ Breast Cancer Brain Metastases Translational Breast Cancer Research Consortium Trial 022,” was presented by Rachel A Freedman, MD, MPH, Breast Oncology Center, Susan F. Smith Center for Wome...

Read More

Industrial Impact, Medical

MODERNA AND GENERATION BIO ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP NON-VIRAL GENETIC MEDICINES

Accesswire | March 24, 2023

news image

Moderna, Inc. a biotechnology company pioneering messenger RNA therapeutics and vaccines, and Generation Bio Co. a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that the two companies have entered into a strategic collaboration to combine Moderna's biological and technical expertise with core technologies of Generation Bio's non-viral genetic medicine platform. The collaboration aims to expand the application ...

Read More
news image

AI, Industrial Impact

CIMEIO THERAPEUTICS PRESENTS SCIP PLATFORM PROOF-OF-CONCEPT DATA AT ASH

Cimeio | December 12, 2022

The two studies demonstrate proof-of-concept that genetically engineered variants of cell surface receptors harboring single amino acid substitutions are fully functional but evade a paired immunotherapy directed against the wild-type molecule. This technology will enable the development of more efficient and safer targeted conditioning regimens for hematopoietic stem cell transplantation, gene therapies, and opens the path to more efficient cell and immunotherapy-based treatment approaches for ...

Read More
news image

Industrial Impact, Medical

ASAHI KASEI BIOPROCESS AMERICA AND GEMINIBIO ENTER STRATEGIC PARTNERSHIP TO ADVANCE APPLICATION OF INLINE BUFFER FORMULATION

businesswire | April 20, 2023

Asahi Kasei Bioprocess America, a subsidiary of diversified Japanese multinational company Asahi Kasei, and GeminiBio have entered into a strategic partnership to advance the application of inline buffer formulation (IBF) in the biopharmaceutical industry. Asahi Kasei Bioprocess, with decades of expertise in IBF and the developers of the award-winning MOTIV™ system, and GeminiBio, with industry leading bioprocess liquid manufacturing capabilities, are combining two high-efficiency so...

Read More
news image

MedTech, Industrial Impact

PUMA BIOTECHNOLOGY PRESENTS UPDATED FINDINGS FROM THE TBCRC-022 TRIAL AT THE 2022 SAN ANTONIO BREAST CANCER SYMPOSIUM

Puma Biotechnology | December 08, 2022

Puma Biotechnology, Inc. a biopharmaceutical company, presented updated findings from the Translational Breast Cancer Research Consortium Trial 022 at the ongoing 2022 San Antonio Breast Cancer Symposium in San Antonio, Texas. The poster entitled “Neratinib and ado-Trastuzumab-Emtansine for HER2+ Breast Cancer Brain Metastases Translational Breast Cancer Research Consortium Trial 022,” was presented by Rachel A Freedman, MD, MPH, Breast Oncology Center, Susan F. Smith Center for Wome...

Read More
news image

Industrial Impact, Medical

MODERNA AND GENERATION BIO ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP NON-VIRAL GENETIC MEDICINES

Accesswire | March 24, 2023

Moderna, Inc. a biotechnology company pioneering messenger RNA therapeutics and vaccines, and Generation Bio Co. a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that the two companies have entered into a strategic collaboration to combine Moderna's biological and technical expertise with core technologies of Generation Bio's non-viral genetic medicine platform. The collaboration aims to expand the application ...

Read More

Resources

resource image

Cell and Gene Therapy, Industrial Impact

GMP Grade PMSF and Protease Inhibitors

Whitepaper

resource image

Cell and Gene Therapy

VIA Thaw™ automated dry thawer

Video

resource image

MedTech, Industrial Impact

Bispecific Antibodies - CMC Considerations

Whitepaper

resource image

Cell and Gene Therapy, Industrial Impact

GMP Grade PMSF and Protease Inhibitors

Whitepaper

resource image

Cell and Gene Therapy

VIA Thaw™ automated dry thawer

Video

resource image

MedTech, Industrial Impact

Bispecific Antibodies - CMC Considerations

Whitepaper

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us